REQUEST A DEMO
Total
USD $0.00
Search more companies

Chi Sheng Pharma & Biotech Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chi Sheng Pharma & Biotech Co., Ltd. Profile Updated: February 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Chi Sheng Chemical Corp. was founded on October 6, 1962 and was listed in OTC on March 6, 1999. It received ISO9001 certification in April 2001 and GMP food certification in April 2003. Chi Sheng is principally engaged in the manufacture and distribution of medical medicines and equipment. The company provides injections, including hemodialysis solutions, amino acid injections and vitamin injections; oral solutions, such as antibiotics, cough syrups and stomach medicines; externally applied medicines, including contact lens solutions, salt solutions and iodine solutions, as well as consumptive products such as healthcare foods. During the year ended December 31, 2009, the company obtained approximately 78.5% and 10.1% of its total revenue from its injection and externally applied medicine businesses, respectively. The company distributes its products in domestic market and to overseas markets, including southeast Asia and mainland China.

Headquarters
No.3, Shijian Rd, Hukou Township
Hsinchu City; Hsinchu City;

Contact Details: Purchase the Chi Sheng Pharma & Biotech Co., Ltd. report to view the information.

Website: http://www.cscp.com.tw/index.php

Basic Information
Total Employees:
Purchase the Chi Sheng Pharma & Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Chi Sheng Pharma & Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Chi Sheng Pharma & Biotech Co., Ltd. report to view the information.
Incorporation Date:
October 06, 1962
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
3.23%
Purchase this report to view the information.
2.8%
Purchase this report to view the information.
2.54%
Purchase this report to view the information.
1.9%
Purchase this report to view the information.
1.76%
Subsidiaries
G Sheng International Limited (Samoa)
100%
Company Performance
Financial values in the chart are available after Chi Sheng Pharma & Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-7.36%
Total operating revenue
-6.26%
Operating profit (EBIT)
-42.72%
EBITDA
-39.9%
Net Profit (Loss) for the Period
-38.66%
Total assets
2.36%
Total equity
5.32%
Operating Profit Margin (ROS)
-3.89%
Net Profit Margin
-3.94%
Return on Equity (ROE)
-3.61%
Debt to Equity Ratio
12.84%
Quick Ratio
0.36%
Cash Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?